Research at the Wilmer Eye Institute on Fuchs Dystrophy

Research at the Wilmer Eye Institute on Fuchs Dystrophy
Important NewsControversy Swirls Around LucentisJulia Haller, professor of ophthalmology at Johns Hopkins explains why controversy swirls around Lucentis, a new drug approved by the FDA for the treatment of macular degeneration. |